Chairman |
||
---|---|---|
Lawrence Gan, Ph.D. 甘良生 博士Director of Taiwan Antibody Association;President/CEO, Foresee Pharmaceuticals Co., Ltd. |
Committee |
||
---|---|---|
Chung-Hsiun Herbert Wu, Ph.D. 吳忠勳 博士President, Development Center for Biotechnology |
||
Wei-Kuang Chi, Ph.D. 紀威光 博士Vice President, Executive Director, Institute of Pharmaceutics,Development Center for Biotechnology |
||
Shih-Chong Tsai, Ph.D. 蔡士昌 博士Executive Director, Institute of Biologics,Development Center for Biotechnology |
||
Chien-Tsun Kuan, Ph.D. 官建村 博士EVP/COO and CTO, GenomeFrontier Therapeutics, Inc. |
||
Karen Wen, Ph.D. 溫國蘭 博士Chief Strategy & Product Development Officer,GenomeFrontier Therapeutics, Inc. |
||
Lee Cheng Liu, Ph.D. 劉理成 博士President/Chief Executive Officer, EirGenix Inc. |